Jang Hyun Cho

Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention

Joo‐Yong Hahn, Young Bin Song, Ju Hyeon Oh et al. · JAMA · 2019 · 588 citations · Full text

6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial

Joo‐Yong Hahn, Young Bin Song, Ju Hyeon Oh et al. · The Lancet · 2018 · 352 citations

Percutaneous Coronary Intervention, Thrombosis, Cardiovascular Disease +9

Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised trial

Chan Joon Kim, Mahn‐Won Park, Min Chul Kim et al. · The Lancet · 2021 · 177 citations

Percutaneous Coronary Intervention, Thrombosis, Cardiovascular Disease +12

Efficacy and safety of clopidogrel versus aspirin monotherapy in patients at high risk of subsequent cardiovascular event after percutaneous coronary intervention (SMART-CHOICE 3): a randomised, open-label, multicentre trial

Ki Hong Choi, Yong Hwan Park, Jong‐Young Lee et al. · The Lancet · 2025 · 46 citations

Thrombosis, Percutaneous Coronary Intervention, Cardiovascular Disease +13

Clinical Usefulness of PRECISE-DAPT Score for Predicting Bleeding Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

Ki Hong Choi, Young Bin Song, Joo Myung Lee et al. · Circulation Cardiovascular Interventions · 2020 · 36 citations